Your browser doesn't support javascript.
loading
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer.
Grubmüller, Bernhard; Senn, Daniela; Kramer, Gero; Baltzer, Pascal; D'Andrea, David; Grubmüller, Karl Hermann; Mitterhauser, Markus; Eidherr, Harald; Haug, Alexander R; Wadsak, Wolfgang; Pfaff, Sarah; Shariat, Shahrokh F; Hacker, Marcus; Hartenbach, Markus.
Afiliação
  • Grubmüller B; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Senn D; Working Group of Diagnostic Imaging in Urology, Austrian Society of Urology, Vienna, Austria.
  • Kramer G; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Baltzer P; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • D'Andrea D; Working Group of Diagnostic Imaging in Urology, Austrian Society of Urology, Vienna, Austria.
  • Grubmüller KH; Department of Biomedical Imaging and Image guided Therapy, Division of General and Pediatric Radiology, Medical University of Vienna, Vienna, Austria.
  • Mitterhauser M; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Eidherr H; Department of Urology and Andrology, University Hospital Krems, Karl Landsteiner University of Health Sciences, Krems, Austria.
  • Haug AR; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Wadsak W; Ludwig Boltzmann Institute for Applied Diagnostics, Vienna, Austria.
  • Pfaff S; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Shariat SF; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Hacker M; Department of Biomedical Imaging and Image Guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
  • Hartenbach M; Center for Biomarker Research in Medicine, CBmed GmbH, Graz, Austria.
Eur J Nucl Med Mol Imaging ; 46(5): 1063-1072, 2019 May.
Article em En | MEDLINE | ID: mdl-30569186
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Glicoproteínas de Membrana / Dipeptídeos / Neoplasias de Próstata Resistentes à Castração / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Compostos Heterocíclicos com 1 Anel Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos Organometálicos / Glicoproteínas de Membrana / Dipeptídeos / Neoplasias de Próstata Resistentes à Castração / Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada / Compostos Heterocíclicos com 1 Anel Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Áustria